Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_assertion type Assertion NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_head.
- NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_assertion description "[A new era in MPN biology began in 2005 with the discovery of a somatic point mutation in JAK2 tyrosine kinase (JAK2V617F), which was identified in a significant proportion of patients with PV, ET and PMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_provenance.
- NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_assertion evidence source_evidence_literature NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_provenance.
- NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_assertion SIO_000772 18754026 NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_provenance.
- NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_assertion wasDerivedFrom befree-20140225 NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_provenance.
- NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_assertion wasGeneratedBy ECO_0000203 NP831909.RAAvFzveI-nbkSSi_4A8gyq-_lliykjnA6jvEDQt2G-A0130_provenance.